Insider trade

ResMed| (RMD): CFO sold ~$812K

Brett Sandercock, CFO at ResMed|, sold ~$812K of ResMed| shares.

~$812K
Approx. value · 3,000 sh @ $270.77
88K
Holds after · shares reported
Traded
Sep 2, 2025
Filed
Sep 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 7, 2025InsiderCEO sold ~$2.06M of RMD shares in the open market
  2. Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$860K)
  3. Aug 7, 2025InsiderCEO sold ~$2.24M of RMD shares in the open market
  4. Aug 18, 2025InsiderDirector sold ~$739K of RMD shares in the open market
  5. Sep 2, 2025 · this disclosureInsiderCFO sold ~$812K of RMD shares in the open market

What came next

  1. Sep 8, 2025InsiderCEO sold ~$2.23M of RMD shares in the open market
  2. Oct 1, 2025Insider · 2 peopleInsiders: 2 sales (~$851K)
  3. Oct 7, 2025InsiderCEO sold ~$2.27M of RMD shares in the open market
  4. Oct 30, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  5. Oct 30, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 13.7%
  6. Nov 3, 2025InsiderCFO sold ~$743K of RMD shares in the open market
  7. Nov 7, 2025InsiderCEO sold ~$2M of RMD shares in the open market
  8. Nov 11, 2025InsiderDirector sold ~$122K of RMD shares in the open market
  9. Nov 12, 2025InsiderDirector sold ~$504K of RMD shares in the open market
  10. Nov 19, 2025Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On November 19, 2025, our board of directors approved reducing the number of directors serving on our board from twelve (12) to eleven (11).”
  11. Nov 25, 2025InsiderDirector sold ~$524K of RMD shares in the open market
  12. Dec 1, 2025Insider · 2 peopleInsiders: 2 sales (~$256K)
  13. Dec 3, 2025InsiderDirector sold ~$503K of RMD shares in the open market
  14. Dec 5, 2025FDAFDA device clearance: Personalized Therapy Comfort Settings (PTCS)
  15. Dec 8, 2025InsiderCEO sold ~$1.25M of RMD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for ResMed|

For ResMed|, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

Other recent filings by Brett Sandercock, Chief Financial Officer

The full history of Brett Sandercock, Chief Financial Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which ResMed| (RMD) insider traded, and how much?

Brett Sandercock, CFO at ResMed|, sold ~$812K of ResMed| shares. 3,000 shares at $270.77.

When did it happen, and when was it made public?

Traded: Sep 2, 2025. Filed: Sep 3, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about ResMed| recently?

For ResMed|, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the RMD page.

Does this mean RMD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at ResMed|

Everything OQRO holds on this company is on its RMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data